BGI Inherited Metabolic Sample (Liquid Chromatography-Tandem Mass Spectrometry) Pretreatment System - Indonesia BPOM Medical Device Registration

BGI Inherited Metabolic Sample (Liquid Chromatography-Tandem Mass Spectrometry) Pretreatment System is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 10102520013. The device is manufactured by SHENZHEN BGI BIOMEDICAL ENGINEERING CO., LTD from China, and is classified as Risk Class Kelas Resiko : A. The authorized representative in Indonesia is INDONESIAN GENOMICS.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.